Daphnetin, ROTICHROM® CHR, 10 mg, envase de vidrio

2-METHYL-1H-IMIDAZOLE-4,5-DICARBONITRILE, 95.0%, 1g

2-Ethoxy-5-methylphenylboronic acid, 95.0%, 10g

(S)-tert-Butyl 1-nicotinoylpyrrolidin-3-ylcarbamate, 95.0%, 1g

Diphenyliodonium hexafluorophosphate, 97.0%, 100g

(R)-Benzyl-2-[4-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazolium Tetrafluoroborate>97.0%(N)1g

Furan-3-boronic acid, 97.00%, 1g

Cyclopenten-1-yl boronic acid, 97.0%, 1g

(R)-N-(4-(TERT-BUTYL)PHENYL)-N-(2-(TERT-BUTYLAMINO)-2-OXO-1-(PYRIDIN-3-YL)ETHYL)FURAN-2-CARBOXAMIDE, 95%, 10mg

4-Dichloromethyl-4-methyl-2,5-cyclohexadienone, 5g

Methyl 2-oxo-1,2-dihydroquinoline-4-carboxylate, 95.0%, 25g

4-((5-Bromo-2-((3-methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)amino)pyrimidin-4-ylamino)methyl)benzenesulfonamide, 98.00%, 50mg

NITROSOBENZENE, 97.0%, 5g